Expression of steroid hormone receptors in BRCA1-associated ovarian carcinomas

Morteza Aghmesheh, Lyndal Edwards, Christine L. Clarke, Karen Byth, Benita S. Katzenellenbogen, Pamela J. Russell, Michael Friedlander, Katherine M. Tucker, Anna De Fazio

Research output: Contribution to journalArticle

Abstract

Objective. BRCA1 mutations predispose to cancer in hormone responsive tissues. A predominance of estrogen receptor (ER)-negative breast cancers in BRCA1 mutation carriers and potential interactions between ERα and BRCA1 suggest a link between hormones and BRCA1. However, the expression pattern of ERα and other hormone receptors in BRCA1-associated ovarian cancer was unknown. Methods. Twenty-two BRCA1-associated ovarian cancer cases were matched with sporadic cases (no family history of ovarian or breast cancer) for FIGO stage, grade, histologic subtype, and patient age and hormone receptor expression was measured immunohistochemically. Results. ERα expression was similar in BRCA1-associated ovarian cancer compared with matched sporadic counterparts, in contrast with previous findings in BRCA1-linked breast cancer. There was also no significant difference in expression of progesterone receptors and androgen receptor between the matched cases in the two groups. However, differences were noted in the relative expression of receptor isotypes, in particular, levels of ERα and ERβ were positively correlated in sporadic tumors but inversely related in BRCA1-associated tumors. Conclusion. Similar hormone receptor expression in BRCA1-associated ovarian cancer and matched sporadic counterparts may be further evidence that at least a proportion of sporadic ovarian tumors and BRCA1-associated tumors develop through similar pathways.

Original languageEnglish (US)
Pages (from-to)16-25
Number of pages10
JournalGynecologic Oncology
Volume97
Issue number1
DOIs
StatePublished - Apr 2005

Fingerprint

Steroid Receptors
Estrogen Receptors
Ovarian Neoplasms
Hormones
Carcinoma
Neoplasms
Breast Neoplasms
Mutation
Androgen Receptors
Progesterone Receptors

Keywords

  • Androgen receptor
  • BRCA1
  • Estrogen receptor
  • Ovarian carcinoma
  • Progesterone receptor

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology

Cite this

Aghmesheh, M., Edwards, L., Clarke, C. L., Byth, K., Katzenellenbogen, B. S., Russell, P. J., ... De Fazio, A. (2005). Expression of steroid hormone receptors in BRCA1-associated ovarian carcinomas. Gynecologic Oncology, 97(1), 16-25. https://doi.org/10.1016/j.ygyno.2004.12.030

Expression of steroid hormone receptors in BRCA1-associated ovarian carcinomas. / Aghmesheh, Morteza; Edwards, Lyndal; Clarke, Christine L.; Byth, Karen; Katzenellenbogen, Benita S.; Russell, Pamela J.; Friedlander, Michael; Tucker, Katherine M.; De Fazio, Anna.

In: Gynecologic Oncology, Vol. 97, No. 1, 04.2005, p. 16-25.

Research output: Contribution to journalArticle

Aghmesheh, M, Edwards, L, Clarke, CL, Byth, K, Katzenellenbogen, BS, Russell, PJ, Friedlander, M, Tucker, KM & De Fazio, A 2005, 'Expression of steroid hormone receptors in BRCA1-associated ovarian carcinomas', Gynecologic Oncology, vol. 97, no. 1, pp. 16-25. https://doi.org/10.1016/j.ygyno.2004.12.030
Aghmesheh, Morteza ; Edwards, Lyndal ; Clarke, Christine L. ; Byth, Karen ; Katzenellenbogen, Benita S. ; Russell, Pamela J. ; Friedlander, Michael ; Tucker, Katherine M. ; De Fazio, Anna. / Expression of steroid hormone receptors in BRCA1-associated ovarian carcinomas. In: Gynecologic Oncology. 2005 ; Vol. 97, No. 1. pp. 16-25.
@article{566565367dc349fb949bf254a617f129,
title = "Expression of steroid hormone receptors in BRCA1-associated ovarian carcinomas",
abstract = "Objective. BRCA1 mutations predispose to cancer in hormone responsive tissues. A predominance of estrogen receptor (ER)-negative breast cancers in BRCA1 mutation carriers and potential interactions between ERα and BRCA1 suggest a link between hormones and BRCA1. However, the expression pattern of ERα and other hormone receptors in BRCA1-associated ovarian cancer was unknown. Methods. Twenty-two BRCA1-associated ovarian cancer cases were matched with sporadic cases (no family history of ovarian or breast cancer) for FIGO stage, grade, histologic subtype, and patient age and hormone receptor expression was measured immunohistochemically. Results. ERα expression was similar in BRCA1-associated ovarian cancer compared with matched sporadic counterparts, in contrast with previous findings in BRCA1-linked breast cancer. There was also no significant difference in expression of progesterone receptors and androgen receptor between the matched cases in the two groups. However, differences were noted in the relative expression of receptor isotypes, in particular, levels of ERα and ERβ were positively correlated in sporadic tumors but inversely related in BRCA1-associated tumors. Conclusion. Similar hormone receptor expression in BRCA1-associated ovarian cancer and matched sporadic counterparts may be further evidence that at least a proportion of sporadic ovarian tumors and BRCA1-associated tumors develop through similar pathways.",
keywords = "Androgen receptor, BRCA1, Estrogen receptor, Ovarian carcinoma, Progesterone receptor",
author = "Morteza Aghmesheh and Lyndal Edwards and Clarke, {Christine L.} and Karen Byth and Katzenellenbogen, {Benita S.} and Russell, {Pamela J.} and Michael Friedlander and Tucker, {Katherine M.} and {De Fazio}, Anna",
year = "2005",
month = "4",
doi = "10.1016/j.ygyno.2004.12.030",
language = "English (US)",
volume = "97",
pages = "16--25",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Expression of steroid hormone receptors in BRCA1-associated ovarian carcinomas

AU - Aghmesheh, Morteza

AU - Edwards, Lyndal

AU - Clarke, Christine L.

AU - Byth, Karen

AU - Katzenellenbogen, Benita S.

AU - Russell, Pamela J.

AU - Friedlander, Michael

AU - Tucker, Katherine M.

AU - De Fazio, Anna

PY - 2005/4

Y1 - 2005/4

N2 - Objective. BRCA1 mutations predispose to cancer in hormone responsive tissues. A predominance of estrogen receptor (ER)-negative breast cancers in BRCA1 mutation carriers and potential interactions between ERα and BRCA1 suggest a link between hormones and BRCA1. However, the expression pattern of ERα and other hormone receptors in BRCA1-associated ovarian cancer was unknown. Methods. Twenty-two BRCA1-associated ovarian cancer cases were matched with sporadic cases (no family history of ovarian or breast cancer) for FIGO stage, grade, histologic subtype, and patient age and hormone receptor expression was measured immunohistochemically. Results. ERα expression was similar in BRCA1-associated ovarian cancer compared with matched sporadic counterparts, in contrast with previous findings in BRCA1-linked breast cancer. There was also no significant difference in expression of progesterone receptors and androgen receptor between the matched cases in the two groups. However, differences were noted in the relative expression of receptor isotypes, in particular, levels of ERα and ERβ were positively correlated in sporadic tumors but inversely related in BRCA1-associated tumors. Conclusion. Similar hormone receptor expression in BRCA1-associated ovarian cancer and matched sporadic counterparts may be further evidence that at least a proportion of sporadic ovarian tumors and BRCA1-associated tumors develop through similar pathways.

AB - Objective. BRCA1 mutations predispose to cancer in hormone responsive tissues. A predominance of estrogen receptor (ER)-negative breast cancers in BRCA1 mutation carriers and potential interactions between ERα and BRCA1 suggest a link between hormones and BRCA1. However, the expression pattern of ERα and other hormone receptors in BRCA1-associated ovarian cancer was unknown. Methods. Twenty-two BRCA1-associated ovarian cancer cases were matched with sporadic cases (no family history of ovarian or breast cancer) for FIGO stage, grade, histologic subtype, and patient age and hormone receptor expression was measured immunohistochemically. Results. ERα expression was similar in BRCA1-associated ovarian cancer compared with matched sporadic counterparts, in contrast with previous findings in BRCA1-linked breast cancer. There was also no significant difference in expression of progesterone receptors and androgen receptor between the matched cases in the two groups. However, differences were noted in the relative expression of receptor isotypes, in particular, levels of ERα and ERβ were positively correlated in sporadic tumors but inversely related in BRCA1-associated tumors. Conclusion. Similar hormone receptor expression in BRCA1-associated ovarian cancer and matched sporadic counterparts may be further evidence that at least a proportion of sporadic ovarian tumors and BRCA1-associated tumors develop through similar pathways.

KW - Androgen receptor

KW - BRCA1

KW - Estrogen receptor

KW - Ovarian carcinoma

KW - Progesterone receptor

UR - http://www.scopus.com/inward/record.url?scp=15544379659&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=15544379659&partnerID=8YFLogxK

U2 - 10.1016/j.ygyno.2004.12.030

DO - 10.1016/j.ygyno.2004.12.030

M3 - Article

C2 - 15790432

AN - SCOPUS:15544379659

VL - 97

SP - 16

EP - 25

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 1

ER -